July 15, 2026 12:17 PM
Study flags need to monitor frailty risks with GLP-1 drugs for older adults
Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study that underscores concerns about how best to monitor seniors as U.S. Medic...
